Evidence map›Paper›PMID 39959558›Full record

ArticleClinical case reports2025

Salvage En Bloc Resection for Refractory Recurrent Pure Testicular Seminoma: A Case Report.

Mohammad Mohammadianpanah, Susan Andalibi, Mansour Ansari, Hamid Nasrollahi, Ahmad Mosalaei, Shapour Omidvari, Maral Mokhtari, Niloofar Ahmadloo, Ehsan Mohammad Hosseini

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammad MohammadianpanahDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.
Susan AndalibiDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0009-0006-3800-1035
Mansour AnsariDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-8249-1776
Hamid NasrollahiDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-7423-3312
Ahmad MosalaeiDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.
Shapour OmidvariDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.
Maral MokhtariDepartment of Pathology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Niloofar AhmadlooDepartment of Radiation Oncology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.
Ehsan Mohammad HosseiniDepartment of Neurosurgery, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-9786-9954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating recurrent or cisplatin-refractory germ cell tumors remains a clinically problematic situation. Although testicular cancer has a good overall cure rate, some patients with metastatic GCTs who did not respond to initial treatments have few therapeutic alternatives and face significant fatality rates. This case showed the successful implementation of radical surgery for patients with refractory seminoma in clinical practice.

Indexed as

chemotherapyseminomasurgical resectiontesticular malignancy

Identifiers

PMID39959558
PMCPMC11825373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.